This document provides an overview and analysis of the pharmaceutical excipients industry in China. Some key points:
- The quality of excipients directly impacts the quality of drug preparations. The development of excipients lags behind China's pharmaceutical industry.
- The report analyzes the industry's development environment, status, competition and provides forecasts. It also examines international industry highlights and compares excipients in China and abroad.
- Major sections include an industry overview, development environment, international overview, China's industry development and competition, development models, and segment market analysis.
China pharmaceutical excipients industry indepth research and investment stra...Qianzhan Intelligence
The document discusses China's pharmaceutical excipients industry. It notes that the quality of excipients directly impacts the quality of drug preparations. The development of excipients in China has lagged the pharmaceutical industry. However, recent events have brought increased attention to excipients and driven their development. The report analyzes the industry's environment, market size, competitors, and prospects for development. It aims to provide a comprehensive overview of the current state and future trends in China's pharmaceutical excipients sector.
China diagnostic reagent industry production & marketing and investment forec...Qianzhan Intelligence
The document provides an overview of the diagnostic reagent industry in China. It discusses that the industry is still in the early stages of development and R&D investment. While China's market size is less than 10% of the global market, some domestic manufacturers have reached international standards in certain technologies. The diagnostic reagent industry attracts investors due to its high profitability, though development remains uneven across different product categories. It predicts continued strong growth in the Chinese market driven by healthcare reforms and expanding demand. The report also profiles several leading multinational and domestic companies in the industry.
China medical device industry market demand and investment strategy report, 2...Qianzhan Intelligence
This document provides an overview and analysis of the medical device industry in China. It discusses the industry's definition and importance to the national economy. It also analyzes the industry's policy environment, economic and social factors, technological development, supply and demand characteristics, imports and exports, competitive landscape, and investment trends. The document contains forecasts for the development prospects of various medical device segment industries and product markets in China from 2013 to 2017. It aims to help industry players better understand the market trends and make informed strategic decisions.
This presentation covers the Introduction to Healthcare & different Products, Role of Pharmaceutical in Healthcare, Drug Details, What a drug is made of ?, Classification of drugs, Product Life Cycle of a Drug, Drug Development Phases, Regulatory Framework & various Regulatory Bodies
Pharmaceutical, Bulk Drugs and Medicine Manufacturing Industry (Production, F...Ajjay Kumar Gupta
Quality control and quality assurance are vital in this industry. Many production workers are assigned full time to quality control and quality assurance functions, whereas other employees may devote part of their time to these functions. For example, although pharmaceutical company sales representatives, often called detailers, work primarily in marketing, they engage in quality control when they assist pharmacists in checking for outdated products.
Advances in manufacturing processes are also impacting the industry. While pharmaceutical manufacturers have long devoted resources to new drug development as a source for future profits, firms are increasingly realizing that improvements throughout the drug pipeline are needed to stay competitive.
See more
http://goo.gl/1sQLwS
http://goo.gl/jajeNa
http://goo.gl/0tvlst
http://www.entrepreneurindia.co/
Tags
Pharmaceutical Technology Books, Essentials of Pharmaceutical Technology, Pharmaceutical Technology, Pharmaceutical books, Science, Technology & Medicine Books, Drugs technology books, Drug and Pharmaceuticals technology book, Best small and cottage scale industries, Bulk Drugs Formulation, Bulk Drugs Manufacturing Industry, Business consultancy, Business consultant, Business guidance for Pharmaceutical industry, Business guidance to clients, Business Plan for a Startup Business, Creating a Pharma Start-up, Drug formulation manual, Formulation of Antibiotics, Formulation of Paracetamol, Formulation of Tablets, Great Opportunity for Startup, How to Start a Medicines manufacturing business?, How to start a pharmaceutical company, How to Start a Pharmaceutical Product Business, How to Start a Pharmaceutical Production Business, How to start a pharmacy business, How to start a successful drugs making business, How to start Antibiotics manufacturing business, How to start drugs pharmaceutical business, How to start medicine business, How to Start Medicine Manufacturing Industry in India, How to start medicine manufacturing, How to start Paracetamol production business, How to Start Pharmaceutical Manufacturing Company in India, Invest to setup a pharmaceutical business, Manufacturing of medicinal products- Pharmaceutical industry, Medicine Manufacturing Industry, Medicines Making Small Business Manufacturing, Modern small and cottage scale industries, Most Profitable Bulk Drugs production Business Ideas, New small scale ideas in Pharmaceutical industry, Pharma Manufacturing, Pharmaceutical and Medicines production Business, Pharmaceutical Based Profitable Projects, Pharmaceutical Based Small Scale Industries Projects, Pharmaceutical Drug Formulation, Pharmaceutical Drug Manufacturing Business, Pharmaceutical formulation guidelines, Pharmaceutical formulation, Pharmaceutical industry in India, Pharmaceutical industry, Pharmaceutical manufacturing Industry in India, Pharmaceutical Manufacturing Industry, Pharmaceutical Projects,
Pharmaceutical sector is one of the most developed hi-tech sectors in Pakistan The growth of the country's pharmaceutical industry has dropped from approximately 16 percent per annum to around eight percent per annum which is a cause of concern not only for the industry but government as well. There is a need of publicly funded R&D institution. Pakistan has to create an enabling infrastructure and linkage to facilitate Pharmaceutical Industry to improve process technique. It is needed to stimulate skill development of Human Resource in Pharmaceutical R&D and to enhance nation’s self-reliance in drugs and pharmaceuticals, especially in areas of national health requirements. Providing technical support to pharmaceutical companies for export is also necessary.
The document discusses the future of the pharmaceutical industry through examining three levels - the inner level of pharmaceutical science/R&D, middle level of business environment, and outer level of healthcare context. For the inner level, it outlines advances in areas like stem cells, medical devices, and personalized medicine. The middle level may see new business models through increased cooperation. For the outer level, it notes how patients are becoming more informed and active in decision making. The document concludes that while the future is difficult to predict, the industry must balance its missions with maintaining public trust.
Contents:
History
DRAP
Composition of DRAP
Function of DRAP
Policy board
Funds and budget of DRAP
Real picture of DRAP
Other agencies
References
History Of Authorities
What Is Drug Regulatory Authority
Drug Regulatory Authority of Pakistan (DRAP) has been established in NOV13,2012 for effective coordination and enforcement of the Drugs Act, 1976.
The Drug Regulatory Authority of Pakistan (DRAP) is an autonomous body working under the administrative control of Ministry of National Health Services.
The Authority is expected to regulate, manufacture, import, export, storage, distribution and sale of therapeutic goods.
What Is Drug Regulatory Authority,…
The authority may set up its establishments including sub-offices and laboratories at province capital and such other places from time to time.
The existing Federal Drug Control Administration(FDCA) and sub offices set up in all provinces are called Central Drug Laboratory
For example;
National Control Laboratory on Biological, Karachi
Federal Drug Surveillance Laboratory, Islamabad
Composition Of DRAP
Chief executive officer
Director Pharmaceutical Evaluations and Registration
Director Drug Licensing
Director Quality Assurance and Laboratory Testing
Director Medical Devices and Medicated Cosmetics
Director Biological Drugs
Composition Of DRAP,….
Director Controlled Drugs
Director Health and OTC Products (non-drugs)
Director Costing and Pricing
Director Budget and Accounts
Director Administration, Human Resource and Logistics
Director Legal Affairs
Director Management Information Services
Power And Function Of DRAP
Evaluation and Registration of pharmaceutical drugs, medical devices and medicated cosmetics, alternative medicines And Licensing of Drug Manufacturing facilities.
Regulation of controlled drugs and biological drugs.
Policy board
DRA will work under the Policy board which consists of 15 members.
Chair person of Board will be Secretary of Federal Health Division
Members will consist of Chief Executive of Agency, Health Secretary of all provinces.
Functions of policy board
Monitor and supervise all function of the DRAP.
Approve the budget of the DRAP.
Determine all fees and leaves.
Funds And Budgets
Loans and grants from the national and international agencies received by the federal government and provincial government to finance the function of the authority.
Grat-in aid in term of salaries and retirements benefits of the existing staff provided by the federal government.
Charges and fees collected by the authority to recover the cost of regulated activities
Funds And Budgets……………
Central research fund collected from pharmaceutical industry.
The authority shall, in respect of each financial year prepare an annual budget for approval from board and shall sent to the federal government for appropriate provision and allocation.
Facts About DRAP
Dr Hussein, regional
China pharmaceutical excipients industry indepth research and investment stra...Qianzhan Intelligence
The document discusses China's pharmaceutical excipients industry. It notes that the quality of excipients directly impacts the quality of drug preparations. The development of excipients in China has lagged the pharmaceutical industry. However, recent events have brought increased attention to excipients and driven their development. The report analyzes the industry's environment, market size, competitors, and prospects for development. It aims to provide a comprehensive overview of the current state and future trends in China's pharmaceutical excipients sector.
China diagnostic reagent industry production & marketing and investment forec...Qianzhan Intelligence
The document provides an overview of the diagnostic reagent industry in China. It discusses that the industry is still in the early stages of development and R&D investment. While China's market size is less than 10% of the global market, some domestic manufacturers have reached international standards in certain technologies. The diagnostic reagent industry attracts investors due to its high profitability, though development remains uneven across different product categories. It predicts continued strong growth in the Chinese market driven by healthcare reforms and expanding demand. The report also profiles several leading multinational and domestic companies in the industry.
China medical device industry market demand and investment strategy report, 2...Qianzhan Intelligence
This document provides an overview and analysis of the medical device industry in China. It discusses the industry's definition and importance to the national economy. It also analyzes the industry's policy environment, economic and social factors, technological development, supply and demand characteristics, imports and exports, competitive landscape, and investment trends. The document contains forecasts for the development prospects of various medical device segment industries and product markets in China from 2013 to 2017. It aims to help industry players better understand the market trends and make informed strategic decisions.
This presentation covers the Introduction to Healthcare & different Products, Role of Pharmaceutical in Healthcare, Drug Details, What a drug is made of ?, Classification of drugs, Product Life Cycle of a Drug, Drug Development Phases, Regulatory Framework & various Regulatory Bodies
Pharmaceutical, Bulk Drugs and Medicine Manufacturing Industry (Production, F...Ajjay Kumar Gupta
Quality control and quality assurance are vital in this industry. Many production workers are assigned full time to quality control and quality assurance functions, whereas other employees may devote part of their time to these functions. For example, although pharmaceutical company sales representatives, often called detailers, work primarily in marketing, they engage in quality control when they assist pharmacists in checking for outdated products.
Advances in manufacturing processes are also impacting the industry. While pharmaceutical manufacturers have long devoted resources to new drug development as a source for future profits, firms are increasingly realizing that improvements throughout the drug pipeline are needed to stay competitive.
See more
http://goo.gl/1sQLwS
http://goo.gl/jajeNa
http://goo.gl/0tvlst
http://www.entrepreneurindia.co/
Tags
Pharmaceutical Technology Books, Essentials of Pharmaceutical Technology, Pharmaceutical Technology, Pharmaceutical books, Science, Technology & Medicine Books, Drugs technology books, Drug and Pharmaceuticals technology book, Best small and cottage scale industries, Bulk Drugs Formulation, Bulk Drugs Manufacturing Industry, Business consultancy, Business consultant, Business guidance for Pharmaceutical industry, Business guidance to clients, Business Plan for a Startup Business, Creating a Pharma Start-up, Drug formulation manual, Formulation of Antibiotics, Formulation of Paracetamol, Formulation of Tablets, Great Opportunity for Startup, How to Start a Medicines manufacturing business?, How to start a pharmaceutical company, How to Start a Pharmaceutical Product Business, How to Start a Pharmaceutical Production Business, How to start a pharmacy business, How to start a successful drugs making business, How to start Antibiotics manufacturing business, How to start drugs pharmaceutical business, How to start medicine business, How to Start Medicine Manufacturing Industry in India, How to start medicine manufacturing, How to start Paracetamol production business, How to Start Pharmaceutical Manufacturing Company in India, Invest to setup a pharmaceutical business, Manufacturing of medicinal products- Pharmaceutical industry, Medicine Manufacturing Industry, Medicines Making Small Business Manufacturing, Modern small and cottage scale industries, Most Profitable Bulk Drugs production Business Ideas, New small scale ideas in Pharmaceutical industry, Pharma Manufacturing, Pharmaceutical and Medicines production Business, Pharmaceutical Based Profitable Projects, Pharmaceutical Based Small Scale Industries Projects, Pharmaceutical Drug Formulation, Pharmaceutical Drug Manufacturing Business, Pharmaceutical formulation guidelines, Pharmaceutical formulation, Pharmaceutical industry in India, Pharmaceutical industry, Pharmaceutical manufacturing Industry in India, Pharmaceutical Manufacturing Industry, Pharmaceutical Projects,
Pharmaceutical sector is one of the most developed hi-tech sectors in Pakistan The growth of the country's pharmaceutical industry has dropped from approximately 16 percent per annum to around eight percent per annum which is a cause of concern not only for the industry but government as well. There is a need of publicly funded R&D institution. Pakistan has to create an enabling infrastructure and linkage to facilitate Pharmaceutical Industry to improve process technique. It is needed to stimulate skill development of Human Resource in Pharmaceutical R&D and to enhance nation’s self-reliance in drugs and pharmaceuticals, especially in areas of national health requirements. Providing technical support to pharmaceutical companies for export is also necessary.
The document discusses the future of the pharmaceutical industry through examining three levels - the inner level of pharmaceutical science/R&D, middle level of business environment, and outer level of healthcare context. For the inner level, it outlines advances in areas like stem cells, medical devices, and personalized medicine. The middle level may see new business models through increased cooperation. For the outer level, it notes how patients are becoming more informed and active in decision making. The document concludes that while the future is difficult to predict, the industry must balance its missions with maintaining public trust.
Contents:
History
DRAP
Composition of DRAP
Function of DRAP
Policy board
Funds and budget of DRAP
Real picture of DRAP
Other agencies
References
History Of Authorities
What Is Drug Regulatory Authority
Drug Regulatory Authority of Pakistan (DRAP) has been established in NOV13,2012 for effective coordination and enforcement of the Drugs Act, 1976.
The Drug Regulatory Authority of Pakistan (DRAP) is an autonomous body working under the administrative control of Ministry of National Health Services.
The Authority is expected to regulate, manufacture, import, export, storage, distribution and sale of therapeutic goods.
What Is Drug Regulatory Authority,…
The authority may set up its establishments including sub-offices and laboratories at province capital and such other places from time to time.
The existing Federal Drug Control Administration(FDCA) and sub offices set up in all provinces are called Central Drug Laboratory
For example;
National Control Laboratory on Biological, Karachi
Federal Drug Surveillance Laboratory, Islamabad
Composition Of DRAP
Chief executive officer
Director Pharmaceutical Evaluations and Registration
Director Drug Licensing
Director Quality Assurance and Laboratory Testing
Director Medical Devices and Medicated Cosmetics
Director Biological Drugs
Composition Of DRAP,….
Director Controlled Drugs
Director Health and OTC Products (non-drugs)
Director Costing and Pricing
Director Budget and Accounts
Director Administration, Human Resource and Logistics
Director Legal Affairs
Director Management Information Services
Power And Function Of DRAP
Evaluation and Registration of pharmaceutical drugs, medical devices and medicated cosmetics, alternative medicines And Licensing of Drug Manufacturing facilities.
Regulation of controlled drugs and biological drugs.
Policy board
DRA will work under the Policy board which consists of 15 members.
Chair person of Board will be Secretary of Federal Health Division
Members will consist of Chief Executive of Agency, Health Secretary of all provinces.
Functions of policy board
Monitor and supervise all function of the DRAP.
Approve the budget of the DRAP.
Determine all fees and leaves.
Funds And Budgets
Loans and grants from the national and international agencies received by the federal government and provincial government to finance the function of the authority.
Grat-in aid in term of salaries and retirements benefits of the existing staff provided by the federal government.
Charges and fees collected by the authority to recover the cost of regulated activities
Funds And Budgets……………
Central research fund collected from pharmaceutical industry.
The authority shall, in respect of each financial year prepare an annual budget for approval from board and shall sent to the federal government for appropriate provision and allocation.
Facts About DRAP
Dr Hussein, regional
Pharma Uptoday Monthly Magazine Volume 5, Issue Aug 2014Sathish Vemula
This document provides a summary of news and regulatory information related to the pharmaceutical industry. Key points include:
- The FDA released its strategic priorities document and is seeking public comments on how to ensure drug safety throughout a product's lifecycle.
- Novartis' Japan unit and a former employee were charged for allegedly manipulating data related to their blood pressure drug Diovan.
- The TGA published an updated summary of fees and is working to implement eCTD submissions for drug applications.
- The FDA filed a complaint seeking to permanently enjoin a California company from distributing vaginal drug products without approval.
- Industry groups in India are concerned about dependence on China for drug APIs and are calling for policies to promote
The Indian pharmaceutical industry is growing and is projected to be among the top 10 global markets by 2020. It is considered a stable industry with impressive growth trends. New small and medium enterprises will play a substantial role in the industry's growth. Graduates have many conventional career options in areas like sales, manufacturing, quality control, medical affairs, and more. There are also less conventional options in fields like clinical research organizations, medical writing, academics, and emerging areas like digital marketing and IT. With additional short-term training, opportunities increase in regulatory affairs, intellectual property, and pharmacovigilance. Consultancy firms also provide opportunities for pharmacy graduates.
Celebrating Successful completion of one year
"Happy anniversary… Pharma Uptoday"
Thanks a lot to all members & Viewers.
To recap the previous month's pharma highlights to Pharma Uptoday members, Monthly magazine Volume 4 has been released with
News Uptoday
New Guidelines
Audit Findings
Regulation of the Month
This document discusses dossier preparation and submission for regulatory approval of pharmaceutical products. It defines a dossier as a collection of documents on a subject used to propose approval of a new drug. Dossiers contain administrative, quality, nonclinical, and clinical data. Common dossier formats include CTD, ACTD, and eCTD, which are used globally and in various regions. Careful compilation, review, and planning is required to ensure dossiers meet all regulatory requirements for submission.
Current regulatory challenges in indian pharmaceutical industryVikas Rathee
India is the 3rd largest in terms of volume and 13th in terms of value all over the world as we still struggle in terms of quality so in this ppt i show some challenges faced by Indian Pharmaceutical Industry
Regulatory dossier preparation and submission as per CTD formatAvinash sharma
This document provides an overview of regulatory dossier preparation and submission using the Common Technical Document (CTD) format. It defines a regulatory dossier and describes the two main types: ICH-CTD and ASEAN CTD. It lists several countries and their respective regulatory authorities. The CTD is explained as a joint format maintained by regulatory agencies in Europe, Japan, and the US. The five CTD modules are outlined which contain administrative, quality, non-clinical, and clinical information. Finally, it compares paper, NeeS, and eCTD submission formats in terms of features like type, compilation, and submission method.
The global nutraceutical products market is expected to exceed $404 billion by 2024, growing at a 7.32% CAGR. Key drivers include rising health awareness and aging populations increasing demand for supplements. Proteins and amino acids dominate the market due to their nutritional benefits and functional properties in food and pharmaceutical applications. The market is segmented by product type, distribution channel, source, and region. Major players are pursuing growth strategies like new product development to gain market share in this expanding industry.
The document discusses the Common Technical Document (CTD) format for drug applications. It was developed through the International Conference on Harmonization to standardize application formats across regions like Europe, Japan, and the United States. The CTD format organizes drug applications into five modules covering administrative information, overview/summaries, quality/manufacturing, safety/toxicology, and efficacy/clinical data. Adopting a common CTD format provides benefits like reducing redundant testing and facilitating information sharing between regulatory agencies.
Pharmaceutical Products of the Future: 50-Company Biopharma and Traditional P...ReportsnReports
This 220-page report from Kalorama Information analyzes the pharmaceutical pipelines of the top 50 pharmaceutical companies to provide estimates and forecasts of the biopharmaceutical market through 2016. The report covers each company's financial performance, research and development spending, and late-stage drug pipeline. It also examines key issues and trends in the industry, such as biotechnology drug development, mergers and acquisitions, and the growing role of biopharmaceuticals.
The enzymes market is forecast to reach $21,760.9 million by 2026, growing at a CAGR of 9.5% from 2020 to 2026. The carbohydrase segment currently dominates the market. North America generates the highest revenue due to established industries and research. Asia-Pacific is expected to grow the fastest due to increasing adoption in food and consumer goods. The main applications of enzymes include food and beverages, cosmetics, textiles, animal feed, and medical and pharmaceutical uses.
The document discusses the ASEAN Common Technical Dossier (ACTD) format for pharmaceutical product registration applications submitted to ASEAN regulatory authorities. The ACTD format aims to standardize applications to reduce submission time and resources while facilitating regulatory review. It includes four parts covering administrative data, quality, nonclinical, and clinical information. The ACTD guideline describes the sections within each part, including overviews, summaries, study reports, and references. The standard format seeks to provide a consistent and transparent presentation of technical information to support evaluation and understanding of registration applications.
As one of the most important methods to increase production in current global agricultural development, pesticide market presents stable growth in recent years. In 2006-2012, chemical pesticide API (converting into active ingredient) output of China attained CAGR of 18.3%, but declined by 10% in 2013 greatly influenced by backward capacity elimination under stringent environmental protection requirement of pesticide industry. However, the price increase offset the unfavorable impact brought by output dropping, operating revenue of Chinese pesticide industry surged by 19.3% year-on-year to RMB281.3 billion, and total profit reached RMB22.93 billion, presenting a 30.9% YoY rise in 2013.
China is not only the big pesticide producer and consumer, but also the large exporter. In 2013, the pesticide export volume soared up by 22.1% yr-on-yr to 1,095kt, and the export structure experienced significant change. Also in the same year, pesticide preparation exported shared about 60% of total export, being the major variety of pesticide export. In addition, the export volume of herbicide, bactericide and insecticide occupied 68%, 23% and 8% of the total, respectively.
The Common Technical Document (CTD) is an internationally agreed format for organizing the technical requirements submitted to regulatory authorities for drug registration. It provides a harmonized template that is acceptable in all three ICH regions: the U.S., Europe, and Japan. The CTD aims to reduce the resources needed to compile applications, facilitate simultaneous submissions and regulatory information exchange, and allow faster availability of new medicines. It is organized into five modules covering administrative information, summaries, quality, nonclinical reports, and clinical reports. While the CTD format provides benefits like resource savings, there remain limitations as requirements still differ between regions.
HPLC2010 Pharmaceutical Copolymer Excipient Characterization By GPC-FTIRmzhou45
This document discusses using size exclusion chromatography coupled with Fourier transform infrared spectroscopy (SEC/GPC-FTIR) to characterize pharmaceutical copolymer excipients. Specifically:
1. GPC-IR can analyze copolymer compositional drifts across molecular weight distributions by measuring functional group ratios.
2. It is useful for characterizing lot-to-lot and grade-to-grade variations in polymeric excipients from different manufacturing processes.
3. Case studies on copovidone and HPMCAS excipients show how GPC-IR detects compositional differences between samples and grades.
Good manufacturing practices (gmp) for pharmaceutical excipientsDurgasai Relangi
This document outlines Good Manufacturing Practices (GMP) for pharmaceutical excipients. It provides minimum requirements for GMP applicable to all excipients. The principles aim to achieve excipient quality, establish control of manufacturing processes, and facilitate continual improvement. Key elements include quality management system requirements, documentation control, management responsibility and review. The GMP principles are intended to ensure excipients meet quality attributes necessary for drug products and regulatory standards.
This document discusses various types of pharmaceutical excipients used in compounding dosage forms. It lists 16 important excipients including antioxidants, preservatives, acidifying agents, and alkalizing agents. Details are provided on the chemistry, physical properties and uses of some specific excipients including ascorbic acid, BHA, chlorobutanol, sodium bicarbonate and sodium carbonate. Excipients are added to drugs to provide suitable consistency or form and aid in compounding pharmaceutical products.
China modern agriculture business model and industrial chain investment strat...Qianzhan Intelligence
This document provides a summary of a report on the modern agriculture business model and industrial chain in China from 2013 to 2017. It begins with an introduction to the development background and stages of modern agriculture in China. It then analyzes different market segments in modern agriculture, including planting, poultry, livestock cultivation, and aquaculture. Next, it examines business models for different parts of the modern agriculture industrial chain, including agricultural capital suppliers, production, processing and circulation. It concludes by discussing the investment value and integrated business models of the modern agriculture industrial chain in China.
This document discusses the common features of living things. It begins by defining key terms like organism, reproduction, environment, and cell. It then explains that all living things grow and change through development, reproduce by making more of their kind, and respond to their environment. They also communicate using senses like sight, smell, and hearing. The document concludes by explaining that all living things are made of cells, and compares the structures of plant and animal cells.
Edu Glogster is an educational tool for high school and post-secondary students that allows them to create online posters, or "glogs", for class projects. It can be accessed either by signing in with a Google account or creating a separate Edu Glogster account. The document provides tips on how to register for Edu Glogster separately from Glogster and how to create new glogs using the green or pink buttons. It also mentions main features like attachments and options to customize with colors, shapes and themes.
Pharma Uptoday Monthly Magazine Volume 5, Issue Aug 2014Sathish Vemula
This document provides a summary of news and regulatory information related to the pharmaceutical industry. Key points include:
- The FDA released its strategic priorities document and is seeking public comments on how to ensure drug safety throughout a product's lifecycle.
- Novartis' Japan unit and a former employee were charged for allegedly manipulating data related to their blood pressure drug Diovan.
- The TGA published an updated summary of fees and is working to implement eCTD submissions for drug applications.
- The FDA filed a complaint seeking to permanently enjoin a California company from distributing vaginal drug products without approval.
- Industry groups in India are concerned about dependence on China for drug APIs and are calling for policies to promote
The Indian pharmaceutical industry is growing and is projected to be among the top 10 global markets by 2020. It is considered a stable industry with impressive growth trends. New small and medium enterprises will play a substantial role in the industry's growth. Graduates have many conventional career options in areas like sales, manufacturing, quality control, medical affairs, and more. There are also less conventional options in fields like clinical research organizations, medical writing, academics, and emerging areas like digital marketing and IT. With additional short-term training, opportunities increase in regulatory affairs, intellectual property, and pharmacovigilance. Consultancy firms also provide opportunities for pharmacy graduates.
Celebrating Successful completion of one year
"Happy anniversary… Pharma Uptoday"
Thanks a lot to all members & Viewers.
To recap the previous month's pharma highlights to Pharma Uptoday members, Monthly magazine Volume 4 has been released with
News Uptoday
New Guidelines
Audit Findings
Regulation of the Month
This document discusses dossier preparation and submission for regulatory approval of pharmaceutical products. It defines a dossier as a collection of documents on a subject used to propose approval of a new drug. Dossiers contain administrative, quality, nonclinical, and clinical data. Common dossier formats include CTD, ACTD, and eCTD, which are used globally and in various regions. Careful compilation, review, and planning is required to ensure dossiers meet all regulatory requirements for submission.
Current regulatory challenges in indian pharmaceutical industryVikas Rathee
India is the 3rd largest in terms of volume and 13th in terms of value all over the world as we still struggle in terms of quality so in this ppt i show some challenges faced by Indian Pharmaceutical Industry
Regulatory dossier preparation and submission as per CTD formatAvinash sharma
This document provides an overview of regulatory dossier preparation and submission using the Common Technical Document (CTD) format. It defines a regulatory dossier and describes the two main types: ICH-CTD and ASEAN CTD. It lists several countries and their respective regulatory authorities. The CTD is explained as a joint format maintained by regulatory agencies in Europe, Japan, and the US. The five CTD modules are outlined which contain administrative, quality, non-clinical, and clinical information. Finally, it compares paper, NeeS, and eCTD submission formats in terms of features like type, compilation, and submission method.
The global nutraceutical products market is expected to exceed $404 billion by 2024, growing at a 7.32% CAGR. Key drivers include rising health awareness and aging populations increasing demand for supplements. Proteins and amino acids dominate the market due to their nutritional benefits and functional properties in food and pharmaceutical applications. The market is segmented by product type, distribution channel, source, and region. Major players are pursuing growth strategies like new product development to gain market share in this expanding industry.
The document discusses the Common Technical Document (CTD) format for drug applications. It was developed through the International Conference on Harmonization to standardize application formats across regions like Europe, Japan, and the United States. The CTD format organizes drug applications into five modules covering administrative information, overview/summaries, quality/manufacturing, safety/toxicology, and efficacy/clinical data. Adopting a common CTD format provides benefits like reducing redundant testing and facilitating information sharing between regulatory agencies.
Pharmaceutical Products of the Future: 50-Company Biopharma and Traditional P...ReportsnReports
This 220-page report from Kalorama Information analyzes the pharmaceutical pipelines of the top 50 pharmaceutical companies to provide estimates and forecasts of the biopharmaceutical market through 2016. The report covers each company's financial performance, research and development spending, and late-stage drug pipeline. It also examines key issues and trends in the industry, such as biotechnology drug development, mergers and acquisitions, and the growing role of biopharmaceuticals.
The enzymes market is forecast to reach $21,760.9 million by 2026, growing at a CAGR of 9.5% from 2020 to 2026. The carbohydrase segment currently dominates the market. North America generates the highest revenue due to established industries and research. Asia-Pacific is expected to grow the fastest due to increasing adoption in food and consumer goods. The main applications of enzymes include food and beverages, cosmetics, textiles, animal feed, and medical and pharmaceutical uses.
The document discusses the ASEAN Common Technical Dossier (ACTD) format for pharmaceutical product registration applications submitted to ASEAN regulatory authorities. The ACTD format aims to standardize applications to reduce submission time and resources while facilitating regulatory review. It includes four parts covering administrative data, quality, nonclinical, and clinical information. The ACTD guideline describes the sections within each part, including overviews, summaries, study reports, and references. The standard format seeks to provide a consistent and transparent presentation of technical information to support evaluation and understanding of registration applications.
As one of the most important methods to increase production in current global agricultural development, pesticide market presents stable growth in recent years. In 2006-2012, chemical pesticide API (converting into active ingredient) output of China attained CAGR of 18.3%, but declined by 10% in 2013 greatly influenced by backward capacity elimination under stringent environmental protection requirement of pesticide industry. However, the price increase offset the unfavorable impact brought by output dropping, operating revenue of Chinese pesticide industry surged by 19.3% year-on-year to RMB281.3 billion, and total profit reached RMB22.93 billion, presenting a 30.9% YoY rise in 2013.
China is not only the big pesticide producer and consumer, but also the large exporter. In 2013, the pesticide export volume soared up by 22.1% yr-on-yr to 1,095kt, and the export structure experienced significant change. Also in the same year, pesticide preparation exported shared about 60% of total export, being the major variety of pesticide export. In addition, the export volume of herbicide, bactericide and insecticide occupied 68%, 23% and 8% of the total, respectively.
The Common Technical Document (CTD) is an internationally agreed format for organizing the technical requirements submitted to regulatory authorities for drug registration. It provides a harmonized template that is acceptable in all three ICH regions: the U.S., Europe, and Japan. The CTD aims to reduce the resources needed to compile applications, facilitate simultaneous submissions and regulatory information exchange, and allow faster availability of new medicines. It is organized into five modules covering administrative information, summaries, quality, nonclinical reports, and clinical reports. While the CTD format provides benefits like resource savings, there remain limitations as requirements still differ between regions.
HPLC2010 Pharmaceutical Copolymer Excipient Characterization By GPC-FTIRmzhou45
This document discusses using size exclusion chromatography coupled with Fourier transform infrared spectroscopy (SEC/GPC-FTIR) to characterize pharmaceutical copolymer excipients. Specifically:
1. GPC-IR can analyze copolymer compositional drifts across molecular weight distributions by measuring functional group ratios.
2. It is useful for characterizing lot-to-lot and grade-to-grade variations in polymeric excipients from different manufacturing processes.
3. Case studies on copovidone and HPMCAS excipients show how GPC-IR detects compositional differences between samples and grades.
Good manufacturing practices (gmp) for pharmaceutical excipientsDurgasai Relangi
This document outlines Good Manufacturing Practices (GMP) for pharmaceutical excipients. It provides minimum requirements for GMP applicable to all excipients. The principles aim to achieve excipient quality, establish control of manufacturing processes, and facilitate continual improvement. Key elements include quality management system requirements, documentation control, management responsibility and review. The GMP principles are intended to ensure excipients meet quality attributes necessary for drug products and regulatory standards.
This document discusses various types of pharmaceutical excipients used in compounding dosage forms. It lists 16 important excipients including antioxidants, preservatives, acidifying agents, and alkalizing agents. Details are provided on the chemistry, physical properties and uses of some specific excipients including ascorbic acid, BHA, chlorobutanol, sodium bicarbonate and sodium carbonate. Excipients are added to drugs to provide suitable consistency or form and aid in compounding pharmaceutical products.
China modern agriculture business model and industrial chain investment strat...Qianzhan Intelligence
This document provides a summary of a report on the modern agriculture business model and industrial chain in China from 2013 to 2017. It begins with an introduction to the development background and stages of modern agriculture in China. It then analyzes different market segments in modern agriculture, including planting, poultry, livestock cultivation, and aquaculture. Next, it examines business models for different parts of the modern agriculture industrial chain, including agricultural capital suppliers, production, processing and circulation. It concludes by discussing the investment value and integrated business models of the modern agriculture industrial chain in China.
This document discusses the common features of living things. It begins by defining key terms like organism, reproduction, environment, and cell. It then explains that all living things grow and change through development, reproduce by making more of their kind, and respond to their environment. They also communicate using senses like sight, smell, and hearing. The document concludes by explaining that all living things are made of cells, and compares the structures of plant and animal cells.
Edu Glogster is an educational tool for high school and post-secondary students that allows them to create online posters, or "glogs", for class projects. It can be accessed either by signing in with a Google account or creating a separate Edu Glogster account. The document provides tips on how to register for Edu Glogster separately from Glogster and how to create new glogs using the green or pink buttons. It also mentions main features like attachments and options to customize with colors, shapes and themes.
El documento describe la enseñanza asistida por computadoras, que utiliza programas educativos como herramientas de aprendizaje. Existen diferentes formas como la enseñanza tutorial, ejercitación, juegos, simulación y herramientas. Los medios incluyen visuales como impresos y diapositivas, y audiovisuales como video, televisión y presentaciones digitales. Ofrece ventajas como adaptarse a horarios apretados y motivar a estudiantes, pero también desventajas como respuestas limitadas versus un profesor y costos elev
This document summarizes a presentation about evaluating sales achievements and customer satisfaction at a dealership in Salatiga, Indonesia. It discusses empowering customer service officers as leaders, keeping in touch with customers through weekly visits and gatherings, and accomplishing results like good customer satisfaction and market share. Maintaining results involves activities like customer repeat orders, service shop customer data, and industry networking events. The presentation aims to hit sales targets through empowering culture and boosting teamwork.
China automated warehouse industry investment demand and development prospect...Qianzhan Intelligence
This document provides an overview and analysis of the automated warehouse industry in China. It discusses the business model and environment of the industry, experiences of automated warehouses in foreign countries, and the development status of the industry in China. Some key points include:
- The market size of China's logistics system reached RMB 30 trillion in 2012, while the automated warehouse market was RMB 6.7 trillion. Both markets are expected to continue growing rapidly.
- The report analyzes the industry from multiple perspectives including technology trends, regional development, and supporting equipment industries.
- It aims to help companies understand the latest industry trends, identify opportunities, and make informed business decisions regarding the automated warehouse sector in China.
Mickey Shariff has over 30 years of experience in the global fashion industry working across apparel and accessories. He is currently the Head of Production and Commercial at Marc b Ltd where he oversees production, development, sales, concessions, and e-commerce. Previously, he held roles such as Head of Production at RTW Group and Co-Founder of Factor Of Three Ltd.
China food safety testing industry development prospects and investment oppor...Qianzhan Intelligence
The document provides an overview and analysis of the China food safety testing industry from 2011-2018. It discusses the status of the food manufacturing industry and food testing in China. It also examines the management system, risks, barriers, and investment focuses of the food safety testing industry in China. The report aims to help readers understand the development trends and opportunities in this industry.
I took a trip to London where I saw many famous landmarks like Big Ben and Buckingham Palace. The city was beautiful and there was so much history everywhere I went. Overall it was an amazing trip that I will remember for a long time.
Kylie Jenner is an American reality television personality, socialite, and model. She is best known for appearing on the E! reality television show Keeping Up with the Kardashians. Jenner owns a successful cosmetics company called Kylie Cosmetics and uses social media extensively to promote her brand and lifestyle. She has a large following on Snapchat, Instagram, and other platforms where she shares details of her daily life and business ventures.
The Joseph K. Heyman Scholarship for Economics StudentsDonald L. Koch
Donald L. Koch teaches finance at the Georgia Institute of Technology and manages the Missouri-based Koch Asset Management with more than 40 years of experience in finance and economics. Donald L. Koch also maintains membership with the Atlanta Economics Club (AEC), which supports new careers in economics through the Joseph K. Heyman Scholarship.
China animal husbandry indepth research and investment forecast reportQianzhan Intelligence
This document provides an overview and analysis of China's animal husbandry industry from 1949 to present day. It summarizes that China's annual animal husbandry output value has increased substantially over time, from 3.37 billion yuan in 1949 to over 2 trillion yuan in 2010. It also outlines government plans to further increase livestock and poultry production scales and output values. Additionally, the document indicates that China now ranks first globally in meat and egg output and third in dairy production, with per capita consumption of animal products also rising significantly since 1978. The report aims to analyze various aspects of China's animal husbandry industry and provide market data and forecasts to help guide industry decisions.
Passive transport moves substances through cell membranes without energy input via diffusion or osmosis, the diffusion of water. Active transport requires energy to move materials and uses transport proteins. Endocytosis and exocytosis involve transport of materials into and out of cells.
China pharmaceutical excipients industry indepth research and investment stra...Qianzhan Intelligence
The document discusses the pharmaceutical excipients industry in China. It notes that the quality of excipients directly impacts the quality of pharmaceutical preparations. The development of the excipients industry in China lags behind the pharmaceutical industry. The report analyzes the industrial environment, development status, challenges, and opportunities for the Chinese excipients industry. It also compares the industry to international standards and practices. The report provides an overview of the industry's development prospects and competitive landscape.
China pharmaceutical excipients industry indepth research and investment stra...Qianzhan Intelligence
The document discusses China's pharmaceutical excipients industry. It notes that the quality of excipients directly impacts the quality of drug preparations. The development of excipients in China has lagged the pharmaceutical industry. However, recent events have brought increased attention to excipients and driven their healthy development. The report analyzes the industry's environment, market size, competitors, and prospects for development. It aims to help readers understand the industry's trends to seize opportunities and make informed decisions.
China pharmaceutical excipients industry indepth research and investment stra...Qianzhan Intelligence
The document discusses the pharmaceutical excipients industry in China. It provides an overview of the industry, including definitions and classifications of excipients. It also analyzes the industry's development environment, highlighting factors like economic conditions, policies, and technology. Internationally, the report examines major excipient-producing countries and regions, comparing management approaches. It then assesses the development, competition, and models of China's excipients industry, identifying issues and opportunities. Overall, the document conducts a comprehensive analysis of the pharmaceutical excipients sector in China and globally.
China pharmaceutical excipients industry indepth research and investment stra...Qianzhan Intelligence
The document discusses the pharmaceutical excipients industry in China. It notes that the quality of excipients directly impacts the quality of pharmaceutical preparations. It also discusses the industrial chain of the excipients industry and its interactions with the preparations industry. The excipients industry supports the development of preparations, while the preparations industry drives demand for higher quality excipients. The report aims to comprehensively analyze the current state and development trends of China's excipients industry through market data and forecasts. It covers topics such as industry scale, competition, development models, and strategies.
China chemical medicine preparation industry production & marketing demand an...Qianzhan Intelligence
This document provides an overview and analysis of the chemical medicine preparation industry in China. It begins with definitions of key terms and classifications of products in the industry. It then analyzes the development environment, size, profitability, import/export markets, and competitive landscape of the industry. It also examines the industry supply chain, development trends, and leading companies. The document aims to help readers understand the current state and future prospects of China's chemical medicine preparation industry.
China chemical medicine preparation industry production & marketing demand an...Qianzhan Intelligence
This document provides an overview and analysis of the chemical medicine preparation industry in China. It begins with definitions of key terms and classifications of products in the industry. It then analyzes the development environment, size, profitability, import/export markets, and competitive landscape of the industry. It also examines the industry supply chain, development trends, and leading companies. The document aims to help readers understand the current state and future prospects of China's chemical medicine preparation industry.
China chemical medicine preparation industry production & marketing demand an...Qianzhan Intelligence
This document provides an overview and analysis of the chemical medicine preparation industry in China. Some key points:
9
Chemical Medicine Preparation Industry
1. The chemical medicine preparation industry is an important part of China's pharmaceutical industry and national economy. It has experienced rapid growth in recent years.
2. The industry is in a competitive stage and faces opportunities as well as challenges. Domestic brands are gradually entering the high-end market while foreign brands still dominate.
3. The report analyzes the industry's development environment, economic indicators, supply and demand, market competition, major product markets, and forecasts future trends. It aims to help industry players make wise decisions.
China chemical medicine preparation industry production & marketing demand an...Qianzhan Intelligence
This document provides an overview and analysis of the chemical medicine preparation industry in China. It begins with definitions of key terms and classifications of products in the industry. It then analyzes the development environment, size, profitability, import/export markets, and competitive landscape of the industry. It also examines the industry supply chain, development trends, and leading companies. The document aims to help readers understand the current state and future prospects of China's chemical medicine preparation industry.
China pharmaceutical business market forecast and investment strategy report,...Qianzhan Intelligence
This document provides an overview and summary of the Chinese Pharmaceutical Business Market Forecast and Investment Strategy Report from 2013 to 2017. It discusses the objectives and importance of the report, which is to provide an accurate and comprehensive analysis of the pharmaceutical business industry in China. This includes analyzing aspects such as industry policies, economic environment, market demand, development status and prospects, competition among major companies, status of pharmaceutical wholesaling and logistics markets, and more. The document emphasizes the report's focus on insight and timeliness to help readers understand the latest industry trends and make correct business and investment decisions.
China diagnostic reagent industry production & marketing and investment forec...Qianzhan Intelligence
The document provides an overview of the diagnostic reagent industry in China. It discusses that the industry is still in the early stages of development and R&D investment, with China's market size being less than 1/10 of the global market. Technological levels have reached international standards in some areas like PCR and gene chips, but other areas like microbiology are relatively underdeveloped. The diagnostic reagent industry attracts investment due to its high profitability, with new products generally recovering costs within 2-3 years. The report forecasts continued growth in the Chinese market driven by healthcare reform and increasing demand.
China cardiovascular system drugs industry market demand forecast and investm...Qianzhan Intelligence
This document provides an analysis of the cardiovascular system drugs industry in China from 2012-2016. It discusses the prevalence of cardiovascular diseases in China and analyzes the market and competitive landscape of the cardiovascular drugs industry. The analysis covers international and domestic market sizes, major drug categories, and profiles 11 leading Chinese pharmaceutical companies in the cardiovascular drugs sector.
China cardiovascular system drugs industry market demand forecast and investm...Qianzhan Intelligence
This document provides an analysis of the cardiovascular system drugs industry in China from 2012-2016. It discusses the prevalence of cardiovascular diseases in China and analyzes the market and competitive landscape of the cardiovascular drugs industry. The analysis covers international and domestic market sizes, major drug categories, and profiles 11 leading Chinese pharmaceutical companies in the cardiovascular drugs sector.
China cardiovascular system drugs industry market demand forecast and investm...Qianzhan Intelligence
This document provides an analysis of the cardiovascular system drugs industry in China from 2012-2016. It discusses the prevalence of cardiovascular diseases in China and analyzes the market and competitive landscape of the cardiovascular drugs industry. The analysis covers international and domestic market sizes, major drug categories, and profiles 11 leading Chinese pharmaceutical companies in the cardiovascular drugs sector.
China cardiovascular system drugs industry market demand forecast and investm...Qianzhan Intelligence
This document provides an analysis of the cardiovascular system drugs industry in China from 2012-2016. It discusses the prevalence of cardiovascular diseases in China and analyzes the market and competitive landscape of the cardiovascular drugs industry. The analysis covers international and domestic market sizes, major drug categories, leading manufacturers, and development trends in the industry. Case studies are also provided of major Chinese pharmaceutical companies in the cardiovascular drugs market.
China cardiovascular system drugs industry market demand forecast and investm...Qianzhan Intelligence
This document provides an analysis of the cardiovascular system drugs industry in China from 2012-2016. It discusses the prevalence of cardiovascular diseases in China and analyzes the market and competitive landscape of the cardiovascular drugs industry. The analysis covers international and domestic market sizes, major drug categories, leading manufacturers, and development trends in the industry. Case studies are also provided of major Chinese pharmaceutical companies in the cardiovascular drugs market.
China cardiovascular system drugs industry market demand forecast and investm...Qianzhan Intelligence
This document provides an analysis of the cardiovascular system drugs industry in China from 2012-2016. It discusses the prevalence of cardiovascular diseases in China and analyzes the market and competitive landscape of the cardiovascular drugs industry. The analysis covers international and domestic market sizes, major drug categories, and profiles 11 leading Chinese pharmaceutical companies in the cardiovascular drugs sector.
China cardiovascular system drugs industry market demand forecast and investm...Qianzhan Intelligence
This document provides an analysis of the cardiovascular system drugs industry in China from 2012-2016. It discusses the prevalence of cardiovascular diseases in China and analyzes the market and competitive landscape of the cardiovascular drugs industry. The analysis covers international and domestic market sizes, major drug categories, leading manufacturers, and development trends in the industry. Case studies are also provided of major Chinese pharmaceutical companies in the cardiovascular drugs market.
Similar to China pharmaceutical excipients industry indepth research and investment strategy report, 2013 2018 (20)
China coal chemical equipment industry report, extensive market research and ...Qianzhan Intelligence
This report provides an extensive market analysis of China's coal chemical equipment industry. It analyzes the industry's structure, current market size, growth rate, and competitive landscape. The report also forecasts future development trends in the industry based on past market data. It aims to help companies understand the latest industry developments to identify opportunities and make strategic business decisions. The report finds that coal chemical projects are accelerating and domestic coal chemical equipment enterprises are growing rapidly. It also notes that accurately understanding industry changes can help companies formulate successful strategies and avoid investment risks.
China rfid industry market forecast and investment strategy planning report, ...Qianzhan Intelligence
This document provides an overview and analysis of the RFID industry in China. It discusses the development environment and status of the RFID industry in China and globally. It also analyzes major players in the global RFID industry and provides details on the market structure, competitive landscape, key applications and hot spots of the RFID industry in China. The report aims to help companies understand the latest trends in order to identify opportunities and make strategic decisions.
China quality testing industry development prospects and investment forecast ...Qianzhan Intelligence
This document provides an overview and analysis of the quality testing industry in China from 2013 to 2017. It discusses the definition and classification of the industry, the background and status of the industry in China's national economy. It also analyzes the development environment, global and domestic trends, competition, downstream demand, and forecasts the development prospects of China's quality testing industry.
China pharmaceutical excipients industry indepth research and investment stra...Qianzhan Intelligence
This document provides an overview and analysis of the pharmaceutical excipients industry in China. Some key points:
- The quality of excipients directly impacts the quality of drug preparations. The development of excipients lags behind China's pharmaceutical industry.
- The report analyzes the industry's development environment, status, competition and provides forecasts. It also examines international industry highlights and compares excipients in China and abroad.
- Major sections include an industry overview, development environment, international overview, China's development and competition, development models, and segment market analysis.
China organosilicon industry production & marketing demand and investment for...Qianzhan Intelligence
Organosilicon consumption in China grew at a compound annual rate of 21% between 2000 and 2010 due to rapid economic growth and expanding applications. China's organosilicon production capacity increased to 1.4 million tons by the end of 2009 and 700,000 additional tons of capacity was added in 2010, with projections of 3 million tons by 2012. As domestic supply increases, it eases shortages and benefits downstream processing industries. Large organosilicon companies are acquiring others and conducting more capital operations as competition grows. Many excellent domestic brands have emerged and become industry leaders by focusing on market research and understanding buyers.
China organosilicon industry market demand prospects and investment strategy ...Qianzhan Intelligence
This document provides an overview and analysis of the organosilicon industry in China from 2013-2017. It analyzes the industry structure, market demand, competitive landscape, development of industry segments, major companies, and development trends and prospects. It finds that with increasing competition, large companies are paying more attention to in-depth market research and customer demand trends. It also provides an analysis of the industry's production, economic benefits, regional distribution of supply and demand, import/export market, policy environment, market segments, and case studies of major companies. The report aims to help companies understand the latest industry trends to gain a competitive advantage.
China new preparation industry marker research and investment forecast reportQianzhan Intelligence
1) The research level of new drug preparation has continuously improved with in-depth exploration of diseases and basic disciplines, and the global new drug preparation industry grew over 10% annually from 2000 to 2009.
2) As China's utilization rate of new drugs is less than 5%, much lower than the global average, the domestic new drug preparation market has great potential for development.
3) The report analyzes the development, market demand, competition and future prospects of China's new drug preparation industry based on Forward's long-term tracking of industry data.
China midwestern cement industry production and marketing demand and investme...Qianzhan Intelligence
1) The document analyzes and forecasts the production, demand, investment, and competitive landscape of China's midwestern cement industry.
2) It finds that in 2010, the midwestern cement industry had over 2,000 enterprises that generated over $206 billion in revenue.
3) The report provides a detailed analysis of factors like industry capacity, demand drivers, policies on eliminating outdated capacity, and the market position of leading companies to make predictions about the future development of the midwestern cement industry.
China micro grid technology progress and prospects forecast report, 2013-2018Qianzhan Intelligence
This document provides a summary of the "China Micro-grid Technology Progress and Prospects Forecast Report, 2013-2018". It discusses the development of micro-grids in China and around the world. The document contains several chapters that analyze topics like the policy environment and status of micro-grids in China, key technology developments, major component prospects, benchmark projects in China, and major research institutes and construction companies. It aims to help readers understand the latest trends in micro-grid development and identify market opportunities.
China methanol industry market research and investment forecast reportQianzhan Intelligence
The document discusses China's methanol industry. It states that China has become the world's largest producer and market for methanol. Methanol production and demand in China have increased rapidly in recent years. The national economy and development of downstream industries such as automobiles, construction, and decoration are supporting further growth in methanol production and consumption in China. The report analyzes factors such as policies, economics, upstream industries, production, demand, imports/exports, regional markets, and projects related to China's methanol industry.
China luxury industry market demand and investment forecast report, 2013 2017Qianzhan Intelligence
This document provides an overview and analysis of the luxury goods industry in China. It discusses the development of the luxury market in China, including the growth in consumption by wealthy Chinese consumers. It also analyzes specific luxury product categories and brands, and examines the business models used by luxury retailers in China. The document aims to help companies understand trends in the luxury industry to identify opportunities and risks.
China retailing industry market forecast and investment strategy planning rep...Qianzhan Intelligence
The document provides an overview and analysis of the China Retailing Industry market from 2013 to 2017. It covers topics such as the development environment, status, major product markets, and regional markets of the China Retailing Industry. The key findings are:
1. The competition in the Retailing Industry is intensifying with frequent mergers and capital operations among large retailers. Leading Chinese retailers are placing more emphasis on in-depth industry and customer research.
2. The report provides a comprehensive analysis of the Retailing Industry using market data tracked over the long term and international analysis models. It covers areas such as development trends, investment prospects, and operations of leading companies.
3. The most significant features of the report
China rfid industry market forecast and investment strategy planning report, ...Qianzhan Intelligence
This document provides an overview and analysis of the RFID industry in China from 2013-2017. It discusses the development of the global and China RFID industry, including market size, major players, policies/plans and applications. The key points are:
1) RFID is seen as an important technology for developing China's Internet of Things industry. The government has issued plans to promote RFID development and applications.
2) The report analyzes the market size, players, policies and applications of the global and China RFID industry. It also examines 10 major application areas in China like transportation, logistics, retail and more.
3) The document aims to help companies understand industry trends, seize opportunities and
China quality testing industry development prospects and investment forecast ...Qianzhan Intelligence
This document provides an overview and analysis of China's quality testing industry from 2013 to 2017. It discusses the industry's definition and classification, development environment, status both globally and within China, competition and leading companies, downstream demand, and forecasts the industry's future development trends. The quality testing industry has grown due to increasing demand from manufacturing, exports, and consumer goods. The report aims to help companies understand the industry's opportunities and make strategic decisions.
China pharmaceutical excipients industry indepth research and investment stra...Qianzhan Intelligence
This document provides an overview and analysis of the pharmaceutical excipients industry in China. Some key points:
- The quality of excipients directly impacts the quality of drug preparations. The development of excipients lags behind China's pharmaceutical industry.
- The report analyzes the industry's development environment, status, competition and provides forecasts. It also examines international industry highlights and compares excipients in China and abroad.
- Major sections include an industry overview, development factors, international overview, China's industry development and competition, development models, and segment market analysis.
China organosilicon industry production & marketing demand and investment for...Qianzhan Intelligence
Organosilicon consumption in China grew at a compound annual rate of 21% between 2000 and 2010 due to rapid economic growth and expanding applications. China's organosilicon production capacity increased to 1.4 million tons by the end of 2009 and 700,000 additional tons of capacity was added in 2010, with projections of 3 million tons by 2012. As domestic supply increases, it eases shortages and benefits downstream processing industries. Large organosilicon companies are acquiring others and conducting more capital operations as competition grows. Many excellent domestic brands have emerged and become industry leaders by focusing on market research and understanding buyers.
China organosilicon industry market demand prospects and investment strategy ...Qianzhan Intelligence
This document provides an overview and analysis of the organosilicon industry in China from 2013-2017. It discusses the industry's development trends, market environment, competition, major segments and products, and profiles leading companies. Specifically, it analyzes factors like economic indexes, supply and demand balances, import/export trends, technological developments, investment patterns, and the operations and strategies of top industry players. The goal is to help companies understand the industry's latest dynamics and identify opportunities for growth.
China new preparation industry marker research and investment forecast reportQianzhan Intelligence
1) The research level of new drug preparation has continuously improved with in-depth exploration of diseases and basic disciplines, and the global new drug preparation industry grew over 10% annually from 2000 to 2009.
2) As China's utilization rate of new drugs is less than 5%, much lower than the global average, the domestic new drug preparation market has great potential for development.
3) The report analyzes the development, market demand, competition and future prospects of China's new drug preparation industry based on Forward's long-term tracking of market data in the industry.
China modern agriculture business model and industrial chain investment strat...Qianzhan Intelligence
This document provides a summary of a report on the modern agriculture business model and industrial chain in China from 2013 to 2017. It discusses the development background of modern agriculture in China and analyzes various segments of the modern agriculture market. It also examines different business unit models across the modern agriculture industrial chain, including agricultural capital suppliers, production, processing, and circulation links. Finally, it evaluates the investment value and business models of the modern agriculture industrial chain in China. The report aims to provide prudent investment solutions and analyze trends in the development of the modern agriculture industry.
China midwestern cement industry production and marketing demand and investme...Qianzhan Intelligence
1) The document analyzes and forecasts the production, demand, investment, and competitive landscape of China's midwestern cement industry.
2) It finds that in 2010, the midwestern cement industry had over 2,000 enterprises that generated over $206 billion in revenue.
3) The report provides a detailed analysis of factors like industry capacity, demand drivers, policies on eliminating outdated capacity, and the positions of leading companies to make predictions about the future development of the midwestern cement industry.
Starting a business is like embarking on an unpredictable adventure. It’s a journey filled with highs and lows, victories and defeats. But what if I told you that those setbacks and failures could be the very stepping stones that lead you to fortune? Let’s explore how resilience, adaptability, and strategic thinking can transform adversity into opportunity.
Call8328958814 satta matka Kalyan result satta guessing➑➌➋➑➒➎➑➑➊➍
Satta Matka Kalyan Main Mumbai Fastest Results
Satta Matka ❋ Sattamatka ❋ New Mumbai Ratan Satta Matka ❋ Fast Matka ❋ Milan Market ❋ Kalyan Matka Results ❋ Satta Game ❋ Matka Game ❋ Satta Matka ❋ Kalyan Satta Matka ❋ Mumbai Main ❋ Online Matka Results ❋ Satta Matka Tips ❋ Milan Chart ❋ Satta Matka Boss❋ New Star Day ❋ Satta King ❋ Live Satta Matka Results ❋ Satta Matka Company ❋ Indian Matka ❋ Satta Matka 143❋ Kalyan Night Matka..
Top 10 Free Accounting and Bookkeeping Apps for Small BusinessesYourLegal Accounting
Maintaining a proper record of your money is important for any business whether it is small or large. It helps you stay one step ahead in the financial race and be aware of your earnings and any tax obligations.
However, managing finances without an entire accounting staff can be challenging for small businesses.
Accounting apps can help with that! They resemble your private money manager.
They organize all of your transactions automatically as soon as you link them to your corporate bank account. Additionally, they are compatible with your phone, allowing you to monitor your finances from anywhere. Cool, right?
Thus, we’ll be looking at several fantastic accounting apps in this blog that will help you develop your business and save time.
Zodiac Signs and Food Preferences_ What Your Sign Says About Your Tastemy Pandit
Know what your zodiac sign says about your taste in food! Explore how the 12 zodiac signs influence your culinary preferences with insights from MyPandit. Dive into astrology and flavors!
Top mailing list providers in the USA.pptxJeremyPeirce1
Discover the top mailing list providers in the USA, offering targeted lists, segmentation, and analytics to optimize your marketing campaigns and drive engagement.
NIMA2024 | De toegevoegde waarde van DEI en ESG in campagnes | Nathalie Lam |...BBPMedia1
Nathalie zal delen hoe DEI en ESG een fundamentele rol kunnen spelen in je merkstrategie en je de juiste aansluiting kan creëren met je doelgroep. Door middel van voorbeelden en simpele handvatten toont ze hoe dit in jouw organisatie toegepast kan worden.
Best Competitive Marble Pricing in Dubai - ☎ 9928909666Stone Art Hub
Stone Art Hub offers the best competitive Marble Pricing in Dubai, ensuring affordability without compromising quality. With a wide range of exquisite marble options to choose from, you can enhance your spaces with elegance and sophistication. For inquiries or orders, contact us at ☎ 9928909666. Experience luxury at unbeatable prices.
Profiles of Iconic Fashion Personalities.pdfTTop Threads
The fashion industry is dynamic and ever-changing, continuously sculpted by trailblazing visionaries who challenge norms and redefine beauty. This document delves into the profiles of some of the most iconic fashion personalities whose impact has left a lasting impression on the industry. From timeless designers to modern-day influencers, each individual has uniquely woven their thread into the rich fabric of fashion history, contributing to its ongoing evolution.
3 Simple Steps To Buy Verified Payoneer Account In 2024SEOSMMEARTH
Buy Verified Payoneer Account: Quick and Secure Way to Receive Payments
Buy Verified Payoneer Account With 100% secure documents, [ USA, UK, CA ]. Are you looking for a reliable and safe way to receive payments online? Then you need buy verified Payoneer account ! Payoneer is a global payment platform that allows businesses and individuals to send and receive money in over 200 countries.
If You Want To More Information just Contact Now:
Skype: SEOSMMEARTH
Telegram: @seosmmearth
Gmail: seosmmearth@gmail.com
[To download this presentation, visit:
https://www.oeconsulting.com.sg/training-presentations]
This PowerPoint compilation offers a comprehensive overview of 20 leading innovation management frameworks and methodologies, selected for their broad applicability across various industries and organizational contexts. These frameworks are valuable resources for a wide range of users, including business professionals, educators, and consultants.
Each framework is presented with visually engaging diagrams and templates, ensuring the content is both informative and appealing. While this compilation is thorough, please note that the slides are intended as supplementary resources and may not be sufficient for standalone instructional purposes.
This compilation is ideal for anyone looking to enhance their understanding of innovation management and drive meaningful change within their organization. Whether you aim to improve product development processes, enhance customer experiences, or drive digital transformation, these frameworks offer valuable insights and tools to help you achieve your goals.
INCLUDED FRAMEWORKS/MODELS:
1. Stanford’s Design Thinking
2. IDEO’s Human-Centered Design
3. Strategyzer’s Business Model Innovation
4. Lean Startup Methodology
5. Agile Innovation Framework
6. Doblin’s Ten Types of Innovation
7. McKinsey’s Three Horizons of Growth
8. Customer Journey Map
9. Christensen’s Disruptive Innovation Theory
10. Blue Ocean Strategy
11. Strategyn’s Jobs-To-Be-Done (JTBD) Framework with Job Map
12. Design Sprint Framework
13. The Double Diamond
14. Lean Six Sigma DMAIC
15. TRIZ Problem-Solving Framework
16. Edward de Bono’s Six Thinking Hats
17. Stage-Gate Model
18. Toyota’s Six Steps of Kaizen
19. Microsoft’s Digital Transformation Framework
20. Design for Six Sigma (DFSS)
To download this presentation, visit:
https://www.oeconsulting.com.sg/training-presentations
SATTA MATKA SATTA FAST RESULT KALYAN TOP MATKA RESULT KALYAN SATTA MATKA FAST RESULT MILAN RATAN RAJDHANI MAIN BAZAR MATKA FAST TIPS RESULT MATKA CHART JODI CHART PANEL CHART FREE FIX GAME SATTAMATKA ! MATKA MOBI SATTA 143 spboss.in TOP NO1 RESULT FULL RATE MATKA ONLINE GAME PLAY BY APP SPBOSS
Satta Matka Dpboss Matka Guessing Kalyan Chart Indian Matka Kalyan panel Chart
China pharmaceutical excipients industry indepth research and investment strategy report, 2013 2018
1. 2011 版
紧固件制造行业
前 瞻 服 务 热 线 : 800-8306390 800-8306395 400-0687188 传 真 : 0755-82940718
service@qianzhan com
China Pharmaceutical Excipients Industry Indepth Research and
Investment Strategy Report, 2013-2018
No comprehensive trend forecast, no gain.
(Help you to discover the unsatisfied market need of pharmaceutical excipients industry, and explicit
the development trend and prospect.)
2. 1
Pharmaceutical Excipients Industry
Preface
Quality of pharmaceutical excipients will produce a direct effect on the quality of preparation products. In
current years, the development of bulk pharmaceutical chemicals is limited by the factors like energy source
and environmental protection. And pharmaceutical industry pays more attention to the development of
preparations. Some outstanding local corporations start to export preparations to developed countries.
Pharmaceutical Industry needs more and better pharmaceutical excipients to support the current preparations
and the development.
The development of China pharmaceutical excipients is behind that of China pharmaceutical industry in long
term. The withdrawing pharmaceutical excipients industry leads to a gap of preparations R&D capability
between China and other countries to a large extent. Along with the explored events like “plasticizer” and
“poison capsule”, pharmaceutical excipients are under the public attention bit by bit. It promotes the healthy
and fast development of pharmaceutical excipients industry. Judging from the 12th
Five Years Planning, the
upgrading and development of pharmaceutical excipients industry is inevitable.
With government’s supports to corporations’ R&D and innovation, the pharmaceutical excipients with good
quality are expanding. The major specialized items of the 12th
Five Years Planning had included
pharmaceutical excipients for the first time. And relevant projects are able to declare at present. It could be
regarded as an active guidance. Besides, the pharmacopoeia in 2015 edition is under amendment. It is
predicted that the category of pharmaceutical excipients will be greatly increased.
Basing on the market data of pharmaceutical excipients market, which tracked and collected by Forward in
long-term, this report provides you an overall analysis system in the height of the whole industry
comprehensively and accurately. This report counts on the macro situation of current pharmaceutical
excipients industry and depends on the production, marketing and demand of nonwoven industry. It gives a
detailed analysis upon China pharmaceutical excipients industry in the aspects of current market capability,
market size, development speed and competitive situation. Furthermore, the rich and completed market data
of Pharmaceutical Excipients products had covered a large range including international segment market,
China market size, market price, productivity, competitive structure, imports and exports and market
prospects. This report is a competitive report of most comprehensive, profound and practical content to
Pharmaceutical Excipients Industry.
This report mainly analyzes the following aspects: development status and highlights of international
Pharmaceutical Excipients Industry; development status of Pharmaceutical Excipients Industry; development
model of Pharmaceutical Excipients Industry; development status of Pharmaceutical Excipients segment
market; development status of Pharmaceutical Excipients Industry in major regions; leading corporations of
3. 2
Pharmaceutical Excipients Industry
Pharmaceutical Excipients Industry; development prospects and investment of Pharmaceutical Excipients
Industry. Meanwhile, the comprehensive and detailed data about nonwoven industry in current years is
contained. In this way, it will help you to maintain the market trend and industry development
comprehensively and accurately.
The most significant features of this report are perceptiveness and timeliness. It is with a forward-looking
analysis of massive first-hand research data; it conducts an in-depth and objective analysis about the overall
market capability, market size, competition structure and market demand characteristics; it gives a prudent
analysis and forecast of pharmaceutical excipients industry according to the industry development track and
Forward’s years of practical experience. In conclusion, it is a significant report to learn about the latest
development trend, grab market opportunities, and make correct marketing decision and explicit corporations’
development trend for all pharmaceutical excipients corporations, R&D institutes, marketing corporations and
Investment corporations. Besides, it is the first heavyweight report to give a comprehensive and systematic
analysis about the upstream and downstream industrial chain, as well as key corporations in pharmaceutical
excipients industry.
Here, we would like to express our sincere gratitude to China Medicine Association, State Information Center,
Bureau of Statistics of China, International Information Research Institute, Chinese Academy of International
Trade and Economic Cooperation, Tsinghua University Library and Development Research Center of the
State Council, for their great support when we conduct this report!
Notice: All the market data, especially corporations' ranking data in the report, only for business reference.
Please do not take the data for enterprise publicity. Thank you! Or Forward shall not take any responsibility
for any consequences!
Forward Business Intelligence Co., Ltd. Industry Research Center
Research Team of Pharmaceutical Excipients Industry
4. 3
Pharmaceutical Excipients Industry
CONTENTS
Chapter I:Overview of China Pharmaceutical Excipients Industry
1.1 Research Background and Methods of the Industry
1.1.1 Research Background of the Industry
1.1.2 Research Method of the Industry
1.2 Concept of Pharmaceutical Excipients
1.2.1 Definition of Pharmaceutical Excipients
1.2.2 Characteristics of Pharmaceutical Excipients
1.3 Classification of Pharmaceutical Excipients
1.4 Business Model of Pharmaceutical Excipients Industry
1.5 Industrial Chain of Pharmaceutical Excipients Industry
1.5.1 Briefing of Pharmaceutical Excipients Industry Chain
1.5.2 Analysis of Pharmaceutical Excipients Upstream Industry
(1) Basic Chemistry Raw-material Manufacturing Industry
(2) Farm and Sideline Food Processing Industry
(3) Food and Feed Additives Manufacturing Industry
1.5.3 Analysis of Pharmaceutical Excipients Downstream Industry
(1) Chemical Medicine Preparations Industry
(2) Chinese Patent Medicine Industry
(3) Bio-pharmaceuticals Industry
1.5.4 Interaction between Preparations and Pharmaceutical Excipients
(1) The Preparations Structure Determine Pharmaceutical Excipients Level
(2) Pharmaceutical Excipients Level Limited Preparations Exports
(3) Preparations Exports is Hopefully Promoting the Development of Pharmaceutical Excipients
Chapter II:Development Environment of China Pharmaceutical Excipients Industry
2.1 Economic Environment of Pharmaceutical Excipients Industry
2.1.1 Analysis of China GDP Growth
2.1.2 Influence of Economic Environment
2.2 Industrial Environment of Pharmaceutical Excipients Industry
2.2.1 Development Status of Pharmaceutical Industry
(1) Development of Pharmaceutical Manufacturing Industry
a. Production and Marketing Scale of Pharmaceutical Manufacturing Industry
5. 4
Pharmaceutical Excipients Industry
b. Development Prospects of Pharmaceutical Manufacturing Industry
(2) Development of Pharmaceutical Commercial Industry
a. Market Size of Pharmaceutical Commercial Industry
b. Market Prospects of Pharmaceutical Commercial Industry
(3) Development of Medical Service Industry
a. Market Size of Medical Service Industry
b. Market Prospects of Medical Service Industry
2.2.2 Influence of Industrial Environment
2.3 Policy Environment of Pharmaceutical Excipients Industry
2.3.1 Administration Departments of the Industry
2.3.2 Administration System of the Industry
2.3.3 Relevant Policies of the Industry
2.4 Social Environment of the Industry
2.4.1 Safety Issue of Pharmaceutical Excipients
2.4.2 Environmental Issue of Pharmaceutical Excipients Industry
2.5 Technology Environment of Pharmaceutical Excipients Industry
2.5.1 Technology Active Degree of the Industry
2.5.2 Patent Output Quality of the Industry
2.5.3 Patent Applicant Structure of the Industry
Chapter III:Overview and Highlights of International Pharmaceutical Excipients Industry
3.1 Overall Development of International Pharmaceutical Excipients Industry
3.1.1 Development Overview of International Pharmaceutical Excipients Industry
(1) Development Status of International Pharmaceutical Excipients Industry
a. The Industry Had Been Well Developed
b. The Industrial Supervision Had Been Gradually Completed
c. The Industrial Standard Had Been Gradually Increased
(2) Development Trend of International New Pharmaceutical Excipients
3.1.2 Market Size of International Pharmaceutical Excipients Industry
3.1.3 Product Structure of International Pharmaceutical Excipients Industry
(1) Organic Pharmaceutical Excipients
(2) Inorganic Pharmaceutical Excipients
(3) Pharmaceutical Water that Meet USP
6. 5
Pharmaceutical Excipients Industry
3.1.4 Competition Status of International Pharmaceutical Excipients Industry
(1) Major Manufacturers of International Pharmaceutical Excipients Industry
(2) Investment, Merger and Reconstruction of International Pharmaceutical Excipients Industry
a. Motivations of Investment, Merger and Reconstruction of International Pharmaceutical
Excipients Industry
b. Ways of Investment, Merger and Reconstruction of International Pharmaceutical Excipients
Industry
3.1.5 Overview of IPEC
3.2 Analysis of Pharmaceutical Excipients Industry in Major Countries
3.2.1 Regional Distribution of International Pharmaceutical Excipients
3.2.2 Analysis of Pharmaceutical Excipients Industry in America
(1) Definition and Classification of Accessory
a. Definition of Accessory
b. Classification of Accessory
(2) Management of New Accessory
a. Definition of New Accessory
b. Declare Requirement of New Accessory
c. Safety Evaluation of Non-clinic
d. DMFIV
(3) Management of Accessory Production
(4) Management of Accessory Operation
(5) Management of Accessory Use
(6) Influence of Pharmacopoeia in New Edition
(7) FDA Accessory Spectrum Database
3.2.3 Analysis of Pharmaceutical Excipients Industry in EU
(1) Definition and Classification of Accessory
a. Definition of Accessory
b. Classification of Accessory
(2) Examine and Approve of New Accessory
a. Definition of New Accessory
b. Declare Requirement of New Accessory
(3) Management of Accessory Production
7. 6
Pharmaceutical Excipients Industry
(4) Management of Accessory Operation
(5) Management of Accessory Use
a. Relevant Requirements to Medicine Application
b. Relevant Requirements to Medicine Dispensatory
3.2.4 Analysis of Pharmaceutical Excipients Industry in Japan
(1) Definition and Classification of Accessory
a. Definition of Accessory
b. Classification of Accessory
(2) Management of Accessory
a. Production of Accessory
b. Management of New Accessory
(3) Standards of Accessory
3.2.5 Comparison of Pharmaceutical Excipients Management among Different Countries
(1) Supervision of Pharmaceutical Excipients
a. Supervision of Pharmaceutical Excipients in the world
b. Supervision of Pharmaceutical Excipients in China
(2) Definition and Classification of Accessory
a. Definition Comparison of Accessory
b. Classification Comparison of Accessory
(3) Comparison of New Accessory Management
a. Definition Comparison of New Accessory
b. Classification Comparison of New Accessory
(4) Comparison of Accessory Production Management
(5) Comparison of Accessory Operation Management
(6) Comparison of Accessory Using Management
a. Existing Problems in China
b. Highlights of the Models in Foreign Countries
3.3 Differences Comparison of Pharmaceutical Excipients at Home and Abroad
3.3.1 Difference of Category and Using Frequency
3.3.2 Difference of Quality Standard
3.3.3 Difference of Testing Method
3.3.4 Difference of R&D
8. 7
Pharmaceutical Excipients Industry
(1) R&D Status of New Accessory in Foreign Countries
a. R&D Emphasizes of New Accessory in Foreign Countries
b. R&D Characteristics of New Accessory in Foreign Countries
(2) R&D Status of New Accessory in China
a. R&D Emphasizes of New Accessory in China
b. R&D Characteristics of New Accessory in China
3.3.5 Difference of Application Research
3.3.6 Difference of Production and Operation
3.4 Analysis of Leading Pharmaceutical Excipients Corporations in the World
3.4.1 Roquette
(1) Development Briefing of the Company
(2) Accessory Business of the Company
(3) Investment of the Company in China
3.4.2 DOW
(1) Development Briefing of the Company
(2) Accessory Business of the Company
(3) Operation Status of the Company
(4) Investment of the Company in China
3.4.3 BASF
(1) Development Briefing of the Company
(2) Accessory Business of the Company
(3) Operation Status of the Company
(4) Investment of the Company in China
3.4.4 ISP
(1) Development Briefing of the Company
(2) Accessory Business of the Company
(3) Investment of the Company in China
3.4.5 Degussa
(1) Development Briefing of the Company
(2) Accessory Business of the Company
(3) Operation Status of the Company
(4) Investment of the Company in China
9. 8
Pharmaceutical Excipients Industry
3.4.6 Gattefosse
(1) Development Briefing of the Company
(2) Accessory Business of the Company
(3) Investment of the Company in China
3.4.7 JRS
(1) Development Briefing of the Company
(2) Accessory Business of the Company
(3) Investment of the Company in China
3.4.8 Asahi Kasei
(1) Development Briefing of the Company
(2) Accessory Business of the Company
(3) Operation Status of the Company
(4) Investment of the Company in China
3.4.9 The Lactose Company of New Zealand Limited
(1) Development Briefing of the Company
(2) Accessory Business of the Company
3.4.10 Hercules Incorporated
(1) Development Briefing of the Company
(2) Accessory Business of the Company
(3) Investment of the Company in China
Chapter IV:Development and Competition Status of China Pharmaceutical Excipients Industry
4.1 Overall Development of China Pharmaceutical Excipients Industry
4.1.1 Development Progress of China Pharmaceutical Excipients Industry
4.1.2 Development Status of China Pharmaceutical Excipients Industry
4.2 Existing Development Problems of China Pharmaceutical Excipients Industry
4.2.1 Unsound Pharmaceutical Excipients Standard System
4.2.2 Uncompleted Pharmaceutical Excipients Management System
4.2.3 Unreasonable Pharmaceutical Excipients Industrial Structure
4.2.4 Great Differences to Same Pharmaceutical Excipients
4.3 Development Scale of China Pharmaceutical Excipients Industry
4.3.1 Prediction through Gross Industrial Output Value
4.3.2 Prediction through Total Output Value of Large-sized Products
10. 9
Pharmaceutical Excipients Industry
4.3.3 Prediction through the Sales Amount of Accessory Corporations
4.4 Competition of China Pharmaceutical Excipients Industry
4.4.1 Structure of the Manufacturing Corporations
4.4.2 Analysis of the Market Share
(1) Market Share of Foreign Corporations
(2) Market Share of China Corporations
4.5 Five Forces Analysis of China Pharmaceutical Excipients Industry
4.5.1 Competition Status of the Industry
4.5.2 Threats from New Entrants
4.5.3 Threats from Substitute Goods
4.5.4 Upstream Bargaining Capability
4.5.5 Downstream Bargaining Capability
4.5.6 Summary of the Competition Status
4.6 Competition Strategy of China Pharmaceutical Excipients Industry
4.6.1 Analysis of Cost Strategy
(1) Applicable Conditions to the Cost Strategy to Pharmaceutical Excipients Industry
(2) Implementation Cases of the Cost Strategy of Pharmaceutical Excipients Industry
4.6.2 Analysis of Differentiation Strategy
(1) Applicable Conditions to the Differentiation Strategy to Pharmaceutical Excipients Industry
(2) Implementation Cases of the Differentiation Strategy of Pharmaceutical Excipients Industry
4.6.3 Analysis of Centralization Strategy
(1) Applicable Conditions to the Centralization Strategy to Pharmaceutical Excipients Industry
(2) Implementation Cases of the Centralization Strategy of Pharmaceutical Excipients Industry
Chapter V:Development Model of China Pharmaceutical Excipients Industry
5.1 Business Models of China Pharmaceutical Excipients Industry
5.1.1 Business Model of "Production plus Sales"
5.1.2 Business Model of "Production plus OEM"
5.1.3 Business Model of "R&D plus Production plus Sales"
5.1.4 Business Model of "Production plus Service"
5.2 Marketing Model of China Pharmaceutical Excipients Industry
5.2.1 Current Marketing Models of China Pharmaceutical Excipients Industry
(1) Direct Selling Model
11. 10
Pharmaceutical Excipients Industry
(2) Selling on Commission Model
(3) Comparison of the Models
5.2.2 New Marketing Models of China Pharmaceutical Excipients Industry
5.3 Brand Strategy of China Pharmaceutical Excipients Industry
5.3.1 Necessity to Brand Construction for Pharmaceutical Excipients Industry
(1) Corporations' Self Own Need
(2) Customers' Need
(3) Competition Need
(4) International Marketing Need
5.3.2 Regional-Brand-to-Nationwide-Brand Strategy of Pharmaceutical Excipients
(1) Regional Brand Status of Pharmaceutical Excipients Industry
(2) Regional Brand Positioning of Pharmaceutical Excipients Industry
(3) Regional Brands' Advantages and Disadvantages of Pharmaceutical Excipients Industry
(4) Breakthrough of Regional Brand to Extend for Pharmaceutical Excipients Industry
a. Management Breakthrough
b. Talent Breakthrough
c. Capital Breakthrough
d. Market Breakthrough
e. Spread-out Breakthrough
5.3.3 Brand Development Suggestions to Pharmaceutical Excipients Industry
(1) Market Upgrading
(2) Brand Upgrading
Chapter VI:Segment Market of China Pharmaceutical Excipients Industry
6.1 Overview of Pharmaceutical Excipients Market
6.2 Analysis of Solid Preparation Material Market
6.2.1 Analysis of Medicinal Sucrose Market
(1) Application Range of Medicinal Sucrose
(2) Market Size of Medicinal Sucrose
(3) Competition of Medicinal Sucrose Market
6.2.2 Analysis of Medicinal Starch Market
(1) Application Range of Medicinal Starch
(2) Market Size of Medicinal Starch
12. 11
Pharmaceutical Excipients Industry
(3) Competition of Medicinal Starch Market
6.2.3 Analysis of Medicinal Cyclodextrin Market
(1) Application Range of Medicinal Cyclodextrin
(2) International Market of Medicinal Cyclodextrin
(3) Market Size of Medicinal Cyclodextrin
(4) Competition of Medicinal Cyclodextrin Market
(5) Imports and Exports of Medicinal Cyclodextrin
6.2.4 Analysis of Medicinal Lactose Market
(1) Application Range of Medicinal Lactose
(2) Pharmacopeia Standards of Medicinal Lactose in New Edition
(3) Competition of Medicinal Lactose Market
6.2.5 Analysis of Medicinal Mannitol Market
(1) Application Range of Medicinal Mannitol
(2) Market Size of Medicinal Mannitol
(3) Competition of Medicinal Mannitol Market
6.2.6 Analysis of Pharmagel Market
(1) Application Range of Pharmagel
(2) New Sources of Pharmagel
(3) International Market of Pharmagel
(4) Market Size of Pharmagel
(5) Competition of Pharmagel Market
6.2.7 Analysis of Medicinal Empty Capsule Market
(1) Market Size of Medicinal Empty Capsule
(2) Competition of Medicinal Empty Capsule Market
(3) Prospects of Medicinal Empty Capsule Market
(4) Market Size of Non-gelatin Medicinal Empty Capsule
(5) Competition of Non-gelatin Medicinal Empty Capsule Market
(6) Prospects of Non-gelatin Medicinal Empty Capsule Market
6.3 Analysis of Liquid Pharmaceutical Adjunct Market
6.3.1 Analysis of Medicinal Beet Red Market
(1) Application Range of Medicinal Beet Red
(2) International Market of Medicinal Beet Red
13. 12
Pharmaceutical Excipients Industry
(3) Market Size of Medicinal Beet Red
(4) Production of Medicinal Beet Red
(5) Competition of Medicinal Beet Red Market
6.3.2 Analysis of Medicinal Stevioside Market
(1) Application Range of Medicinal Stevioside
(2) International Market of Medicinal Stevioside
(3) Production of Medicinal Stevioside
(4) Competition of Medicinal Stevioside Market
(5) Imports and Exports of Medicinal Stevioside
6.3.3 Analysis of Medicinal Soluble Saccharin Market
(1) Application Range of Medicinal Soluble Saccharin
(2) Market Price of Medicinal Soluble Saccharin
(3) Market Size of Medicinal Soluble Saccharin
(4) Imports and Exports of Medicinal Soluble Saccharin
6.3.4 Analysis of Medicinal Aspartame Market
(1) Application Range of Medicinal Aspartame
(2) Market Price of Medicinal Aspartame
(3) International Medicinal Aspartame Market
(4) China Medicinal Aspartame Market
6.3.5 Analysis of Medicinal High Fructose Syrup Market
(1) Application Range of Medicinal High Fructose Syrup
(2) International Medicinal High Fructose Syrup Market
(3)China Medicinal High Fructose Syrup Market
6.3.6 Analysis of Medicinal Xylitol Market
(1) Application Range of Medicinal Xylitol
(2) Development Progress of Medicinal Xylitol Industry
(3) Market Size of Medicinal Xylitol
(4) Competition of Medicinal Xylitol Market
(5) Prospects of Medicinal Xylitol Market
6.3.7 Analysis of Medicinal Maltitol Market
(1) Application Range of Medicinal Maltitol
(2) Development Progress of Medicinal Maltitol Industry
14. 13
Pharmaceutical Excipients Industry
(3) Market Size of Medicinal Maltitol
(4) Competition of Medicinal Maltitol Market
(5) Prospects of Medicinal Maltitol Market
6.3.8 Analysis of Medicinal Sorbitol Market
(1) Application Range of Medicinal Sorbitol
(2) Development Progress of Medicinal Sorbitol Industry
(3) Market Size of Medicinal Sorbitol
(4) Competition of Medicinal Sorbitol Market
6.3.9 Analysis of Medicinal Hyaluronic Acid Market
(1) Application Range of Medicinal Hyaluronic Acid
(2) International Medicinal Hyaluronic Acid Market
(3) China Medicinal Hyaluronic Acid Market
6.4 Analysis of New Pharmaceutical Excipients Market
6.4.1 Sustained-release Preparations
(1) Overview of Sustained-release Preparations
(2) Application of Sustained-release Preparations
(3) Analysis of MCC Market
a. Application Range of MCC Market
b. Market Size of MCC
c. Competition of MCC Market
(4) Analysis of PVP Market
a. Application Range of PVP Market
b. Market Size of PVP
c. Competition of PVP Market
6.4.2 Micro Cyst and Balling
(1) Accessory Classification of Micro Cyst and Balling
(2) Accessory Application of Micro Cyst and Balling
(3) Analysis of Medicinal Chitosan Market
a. Application Range of Medicinal Chitosan
b. Analysis of International Medicinal Chitosan Market
c. Analysis of China Medicinal Chitosan Market
d. Analysis of Medicinal Chitosan Industrialization
15. 14
Pharmaceutical Excipients Industry
(4) Analysis of Medicinal Algal Polysaccharides Market
a. Analysis of Medicinal Agar Market
b. Analysis of Medicinal Carrageenan Market
c. Analysis of Medicinal Sodium Alginate Market
d. Development Prospects of Medicinal Algal Polysaccharides
6.4.3 Premix Accessory
(1) Definition of Premix Accessory
(2) Analysis of Premix Accessory Industrialization
(3) Development Trend of the Industry
6.4.4 Nanometer Accessory
(1) Definition of Nanometer Accessory
(2) Analysis of Nanometer Accessory Industrialization
(3) Development Trend of the Industry
6.4.5 New Accessory of Chinese Herba Preparations
(1) Application of New Accessory in Chinese Hera Preparations
a. Capsule
b. Sustained-release Preparations
c. Dispersible Tablet
d. Cataplasm
e. Transdermal Absorption
f. Microballoon and Lipidosome
(2) Application of New Accessory in Bioavailability
a. Phospholipid Complex
b. Self Microemulsion System
Chapter Ⅶ:Analysis of China Pharmaceutical Excipients Industry in Major Regions
7.1 Development and Forecast of Pharmaceutical Excipients Industry in Shandong Province
7.1.1 Development Overview and Characteristics of Pharmaceutical Excipients Industry in Shandong
Province
(1) Status of Shandong Pharmaceutical Excipients Industry to China
(2) Major Pharmaceutical Excipients Corporations in Shandong Province
(3) Industrial Belt Distribution of Pharmaceutical Excipients Industry in Shandong Province
(4) Characteristics of Pharmaceutical Excipients Industry in Shandong Province
16. 15
Pharmaceutical Excipients Industry
7.1.2 Downstream Demand of Pharmaceutical Excipients Industry in Shandong Province
(1) Chemical Medicine Preparations in Shandong Province
(2) Chinese Patent Medicine Industry in Shandong Province
(3) Bio-pharmaceutical Industry in Shandong Province
7.1.3 Development Prospects Forecast of Pharmaceutical Excipients Industry in Shandong Province
7.2 Development and Forecast of Pharmaceutical Excipients Industry in Jiangsu Province
7.2.1 Development Overview and Characteristics of Pharmaceutical Excipients Industry in Jiangsu
Province
(1) Status of Jiangsu Pharmaceutical Excipients Industry to China
(2) Major Pharmaceutical Excipients Corporations in Jiangsu Province
(3) Industrial Belt Distribution of Pharmaceutical Excipients Industry in Jiangsu Province
(4) Characteristics of Pharmaceutical Excipients Industry in Jiangsu Province
7.2.2 Downstream Demand of Pharmaceutical Excipients Industry in Jiangsu Province
(1) Chemical Medicine Preparations in Jiangsu Province
(2) Chinese Patent Medicine Industry in Jiangsu Province
(3) Bio-pharmaceutical Industry in Jiangsu Province
7.2.3 Development Prospects Forecast of Pharmaceutical Excipients Industry in Jiangsu Province
7.3 Development and Forecast of Pharmaceutical Excipients Industry in Zhejiang Province
7.3.1 Development Overview and Characteristics of Pharmaceutical Excipients Industry in Zhejiang
Province
(1) Status of Zhejiang Pharmaceutical Excipients Industry to China
(2) Major Pharmaceutical Excipients Corporations in Zhejiang Province
(3) Industrial Belt Distribution of Pharmaceutical Excipients Industry in Zhejiang Province
(4) Characteristics of Pharmaceutical Excipients Industry in Zhejiang Province
7.3.2 Downstream Demand of Pharmaceutical Excipients Industry in Zhejiang Province
(1) Chemical Medicine Preparations in Zhejiang Province
(2) Chinese Patent Medicine Industry in Zhejiang Province
(3) Bio-pharmaceutical Industry in Zhejiang Province
7.3.3 Development Prospects Forecast of Pharmaceutical Excipients Industry in Zhejiang Province
7.4 Development and Forecast of Pharmaceutical Excipients Industry in Shanghai City
7.4.1 Development Overview and Characteristics of Pharmaceutical Excipients Industry in Shanghai
City
17. 16
Pharmaceutical Excipients Industry
(1) Status of Shanghai Pharmaceutical Excipients Industry to China
(2) Major Pharmaceutical Excipients Corporations in Shanghai City
(3) Industrial Belt Distribution of Pharmaceutical Excipients Industry in Shanghai City
(4) Characteristics of Pharmaceutical Excipients Industry in Shanghai City
7.4.2 Downstream Demand of Pharmaceutical Excipients Industry in Shanghai City
(1) Chemical Medicine Preparations in Shanghai City
(2) Chinese Patent Medicine Industry in Shanghai City
(3) Bio-pharmaceutical Industry in Shanghai City
7.4.3 Development Prospects Forecast of Pharmaceutical Excipients Industry in Shanghai City
7.5 Development and Forecast of Pharmaceutical Excipients Industry in Jiangxi Province
7.5.1 Development Overview and Characteristics of Pharmaceutical Excipients Industry in Jiangxi
Province
(1) Status of Jiangxi Pharmaceutical Excipients Industry to China
(2) Major Pharmaceutical Excipients Corporations in Jiangxi Province
(3) Industrial Belt Distribution of Pharmaceutical Excipients Industry in Jiangxi Province
(4) Characteristics of Pharmaceutical Excipients Industry in Jiangxi Province
7.5.2 Downstream Demand of Pharmaceutical Excipients Industry in Jiangxi Province
(1) Chemical Medicine Preparations in Jiangxi Province
(2) Chinese Patent Medicine Industry in Jiangxi Province
(3) Bio-pharmaceutical Industry in Jiangxi Province
7.5.3 Development Prospects Forecast of Pharmaceutical Excipients Industry in Jiangxi Province
7.6 Development and Forecast of Pharmaceutical Excipients Industry in Anhui Province
7.6.1 Development Overview and Characteristics of Pharmaceutical Excipients Industry in Anhui
Province
(1) Status of Anhui Pharmaceutical Excipients Industry to China
(2) Major Pharmaceutical Excipients Corporations in Anhui Province
(3) Industrial Belt Distribution of Pharmaceutical Excipients Industry in Anhui Province
(4) Characteristics of Pharmaceutical Excipients Industry in Anhui Province
7.6.2 Downstream Demand of Pharmaceutical Excipients Industry in Anhui Province
(1) Chemical Medicine Preparations in Anhui Province
(2) Chinese Patent Medicine Industry in Anhui Province
(3) Bio-pharmaceutical Industry in Anhui Province
18. 17
Pharmaceutical Excipients Industry
7.6.3 Development Prospects Forecast of Pharmaceutical Excipients Industry in Anhui Province
7.7 Development and Forecast of Pharmaceutical Excipients Industry in Guangdong Province
7.7.1 Development Overview and Characteristics of Pharmaceutical Excipients Industry in
Guangdong Province
(1) Status of Guangdong Pharmaceutical Excipients Industry to China
(2) Major Pharmaceutical Excipients Corporations in Guangdong Province
(3) Industrial Belt Distribution of Pharmaceutical Excipients Industry in Guangdong Province
(4) Characteristics of Pharmaceutical Excipients Industry in Guangdong Province
7.7.2 Downstream Demand of Pharmaceutical Excipients Industry in Guangdong Province
(1) Chemical Medicine Preparations in Guangdong Province
(2) Chinese Patent Medicine Industry in Guangdong Province
(3) Bio-pharmaceutical Industry in Guangdong Province
7.7.3 Development Prospects Forecast of Pharmaceutical Excipients Industry in Guangdong Province
7.8 Development and Forecast of Pharmaceutical Excipients Industry in Henan Province
7.8.1 Development Overview and Characteristics of Pharmaceutical Excipients Industry in Henan
Province
(1) Status of Henan Pharmaceutical Excipients Industry to China
(2) Major Pharmaceutical Excipients Corporations in Henan Province
(3) Industrial Belt Distribution of Pharmaceutical Excipients Industry in Henan Province
(4) Characteristics of Pharmaceutical Excipients Industry in Henan Province
7.8.2 Downstream Demand of Pharmaceutical Excipients Industry in Henan Province
(1) Chemical Medicine Preparations in Henan Province
(2) Chinese Patent Medicine Industry in Henan Province
(3) Bio-pharmaceutical Industry in Henan Province
7.8.3 Development Prospects Forecast of Pharmaceutical Excipients Industry in Henan Province
7.9 Development and Forecast of Pharmaceutical Excipients Industry in Hubei Province
7.9.1 Development Overview and Characteristics of Pharmaceutical Excipients Industry in Hubei
Province
(1) Status of Hubei Pharmaceutical Excipients Industry to China
(2) Major Pharmaceutical Excipients Corporations in Hubei Province
(3) Industrial Belt Distribution of Pharmaceutical Excipients Industry in Hubei Province
(4) Characteristics of Pharmaceutical Excipients Industry in Hubei Province
19. 18
Pharmaceutical Excipients Industry
7.9.2 Downstream Demand of Pharmaceutical Excipients Industry in Hubei Province
(1) Chemical Medicine Preparations in Hubei Province
(2) Chinese Patent Medicine Industry in Hubei Province
(3) Bio-pharmaceutical Industry in Hubei Province
7.9.3 Development Prospects Forecast of Pharmaceutical Excipients Industry in Hubei Province
7.10 Development and Forecast of Pharmaceutical Excipients Industry in Hunan Province
7.10.1 Development Overview and Characteristics of Pharmaceutical Excipients Industry in
Hunan Province
(1) Status of Hunan Pharmaceutical Excipients Industry to China
(2) Major Pharmaceutical Excipients Corporations in Hunan Province
(3) Industrial Belt Distribution of Pharmaceutical Excipients Industry in Hunan Province
(4) Characteristics of Pharmaceutical Excipients Industry in Hunan Province
7.10.2 Downstream Demand of Pharmaceutical Excipients Industry in Hunan Province
(1) Chemical Medicine Preparations in Hunan Province
(2) Chinese Patent Medicine Industry in Hunan Province
(3) Bio-pharmaceutical Industry in Hunan Province
7.10.3 Development Prospects Forecast of Pharmaceutical Excipients Industry in Hunan Province
7.11 Development and Forecast of Pharmaceutical Excipients Industry in Hebei Province
7.11.1 Development Overview and Characteristics of Pharmaceutical Excipients Industry in
Hebei Province
(1) Status of Hebei Pharmaceutical Excipients Industry to China
(2) Major Pharmaceutical Excipients Corporations in Hebei Province
(3) Industrial Belt Distribution of Pharmaceutical Excipients Industry in Hebei Province
(4) Characteristics of Pharmaceutical Excipients Industry in Hebei Province
7.11.2 Downstream Demand of Pharmaceutical Excipients Industry in Hebei Province
(1) Chemical Medicine Preparations in Hebei Province
(2) Chinese Patent Medicine Industry in Hebei Province
(3) Bio-pharmaceutical Industry in Hebei Province
7.11.3 Development Prospects Forecast of Pharmaceutical Excipients Industry in Hebei Province
7.12 Development and Forecast of Pharmaceutical Excipients Industry in Beijing City
7.12.1 Development Overview and Characteristics of Pharmaceutical Excipients Industry in
Beijing City
20. 19
Pharmaceutical Excipients Industry
(1) Status of Beijing Pharmaceutical Excipients Industry to China
(2) Major Pharmaceutical Excipients Corporations in Beijing City
(3) Industrial Belt Distribution of Pharmaceutical Excipients Industry in Beijing City
(4) Characteristics of Pharmaceutical Excipients Industry in Beijing City
7.12.2 Downstream Demand of Pharmaceutical Excipients Industry in Beijing City
(1) Chemical Medicine Preparations in Beijing City
(2) Chinese Patent Medicine Industry in Beijing City
(3) Bio-pharmaceutical Industry in Beijing City
7.12.3 Development Prospects Forecast of Pharmaceutical Excipients Industry in Beijing City
7.13 Development and Forecast of Pharmaceutical Excipients Industry in Tianjin City
7.13.1 Development Overview and Characteristics of Pharmaceutical Excipients Industry in
Tianjin City
(1) Status of Tianjin Pharmaceutical Excipients Industry to China
(2) Major Pharmaceutical Excipients Corporations in Tianjin City
(3) Industrial Belt Distribution of Pharmaceutical Excipients Industry in Tianjin City
(4) Characteristics of Pharmaceutical Excipients Industry in Tianjin City
7.13.2 Downstream Demand of Pharmaceutical Excipients Industry in Tianjin City
(1) Chemical Medicine Preparations in Tianjin City
(2) Chinese Patent Medicine Industry in Tianjin City
(3) Bio-pharmaceutical Industry in Tianjin City
7.13.3 Development Prospects Forecast of Pharmaceutical Excipients Industry in Tianjin City
7.14 Development and Forecast of Pharmaceutical Excipients Industry in Sichuan Province
7.14.1 Development Overview and Characteristics of Pharmaceutical Excipients Industry in
Sichuan Province
(1) Status of Sichuan Pharmaceutical Excipients Industry to China
(2) Major Pharmaceutical Excipients Corporations in Sichuan Province
(3) Industrial Belt Distribution of Pharmaceutical Excipients Industry in Sichuan Province
(4) Characteristics of Pharmaceutical Excipients Industry in Sichuan Province
7.14.2 Downstream Demand of Pharmaceutical Excipients Industry in Sichuan Province
(1) Chemical Medicine Preparations in Sichuan Province
(2) Chinese Patent Medicine Industry in Sichuan Province
(3) Bio-pharmaceutical Industry in Sichuan Province
21. 20
Pharmaceutical Excipients Industry
7.14.3 Development Prospects Forecast of Pharmaceutical Excipients Industry in Sichuan
Province
Chapter VIII:Competition of the Leading Pharmaceutical Excipients Corporations in China
8.1 Overall Status of China Pharmaceutical Excipients Corporations
8.1.1 Fierce Market Competition
8.1.2 Disordered Market
8.1.3 Under R&D Investment
8.1.4 Serious Product Homogeneity
8.2 Analysis of the Leading Pharmaceutical Excipients Corporations in China
8.2.1 Operation of Hun
By Qianzhan Intelligence
Website: http://en.qianzhan.com/
Tel:+86 0755 33220413
Email us: carter@qianzhan.com.cn